Search

Charles Swanton of Cancer Research UK and University College London was one of the recipients of the 2021 Paul Marks Prize for Cancer Research.

… Thursday, March 17, 2022 The Paul Marks Prize for Cancer Research was created by the Boards of Memorial Sloan Kettering Cancer Center to honor the late Paul Marks , who served as President and CEO of MSK for almost 20 years, beginning in 1980. Awarded every other year since 2001, the prize recognizes

Computational biology is helping to bring predictive power and precision to oncology.

… Wednesday, April 1, 2020 By Julie Grisham It was July 17, 2017, when Albert Kuchler found an unusual lump in his neck. As a retired oral surgeon, he knew this was cause for concern. He called his friend and colleague Jatin Shah , a member of Memorial Sloan Kettering’s Head and Neck Service, to see if

Research led by investigators at Memorial Sloan Kettering has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory.

… Thursday, September 4, 2014 Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting new tool to test cancer drugs and personalize cancer

MSK research team identifies unique markers of inflammation and neurodegeneration found in cerebrospinal fluid of cancer patients with altered mental status after initial SARS-CoV-2 infection, as likely cause of neurologic dysfunction.

… Tuesday, March 2, 2021 Unique markers of inflammation and neurodegeneration in cerebrospinal fluid were present several weeks after initial SARS-CoV-2 infection in cancer patients with neurologic symptoms. These inflammatory cytokines were absent in plasma and likely drove the neurologic dysfunction,

Memorial Sloan Kettering Cancer Center today unveiled a new pressroom for journalists with enhanced features as well as the availability of an on-site broadcast studio.

… Tuesday, August 27, 2013 Memorial Sloan Kettering Cancer Center today unveiled a new pressroom for journalists with enhanced features such as embargoed content for registered users and “trending topics” – a continually updated listing of story ideas and available experts to comment on the latest health

Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.

… Friday, January 1, 2021 Thank you to our donor community. Your commitment to supporting Memorial Sloan Kettering Cancer Center is essential to advancing our mission. Read more to learn about your impact in 2021. Fundraising Events at MSK Fred’s Team Participants raised more than $7.3 million in 2021

RSV is a respiratory disease that spreads in the fall and winter months. Learn about the RSV vaccines, which are approved for people ages 50 and older.

… Friday, September 13, 2024 People ages 50 to 74 who are at risk for getting very sick from RSV can get vaccinated, after talking with their doctor. People ages 75 and older should get an RSV vaccine. Mini Kamboj Mini Kamboj Mini Kamboj has answers to some frequently asked questions about the RSV vaccines

Memorial Sloan Kettering and Eureka Therapeutics recently entered into a licensing agreement with Novartis to develop a unique monoclonal antibody.

… Tuesday, January 28, 2014 Using monoclonal antibodies to fight cancer is a complex, yet promising area of study. At Memorial Sloan Kettering Cancer Center, physician-scientists have focused their attention on expanding the current therapeutic antibody repertoire, and believe a newly developed platform

An immunotherapy drug might be an effective initial treatment for people with metastatic Merkel cell carcinoma.

… Thursday, March 22, 2018 Summary Merkel cell carcinoma  is hard to treat after it has spread. A new immunotherapy drug, avelumab, was recently approved by the FDA for people with metastatic Merkel cell carcinoma who had previously received chemotherapy. Now new research suggests avelumab could be even

Learn about lung cancer in women, the links between lung cancer and smoking, the relationship between lung cancer and genetics, and the benefits of being treated at a hospital that offers many clinical trials for lung cancer.

… Friday, January 17, 2025 According to the latest statistics from the American Cancer Society, incidence rates of lung cancer are now higher in women than in men among people younger than 65 years.  Overall, though, the news about lung cancer is largely hopeful. In fact, a 2023 study  from the American